Filing Details
- Accession Number:
- 0001140361-24-046456
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-13 16:05:24
- Reporting Period:
- 2024-11-11
- Accepted Time:
- 2024-11-13 16:05:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 887359 | Vericel Corp | VCEL | Biological Products, (No Disgnostic Substances) (2836) | 943096597 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1220363 | Md L Robert Zerbe | C/O Vericel Corporation 64 Sidney Street Cambridge MA 02139 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-11 | 2,500 | $13.05 | 29,095 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-11 | 2,500 | $55.00 | 26,595 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-11-12 | 2,500 | $13.05 | 29,095 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-12 | 2,500 | $57.50 | 26,595 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2024-11-11 | 2,500 | $0.00 | 2,500 | $13.05 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2024-11-12 | 2,500 | $0.00 | 2,500 | $13.05 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,000 | 2028-05-02 | No | 4 | M | Direct | |
| 12,500 | 2028-05-02 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2024.
- These options, representing the right to purchase 17,500 shares, were originally granted on May 2, 2018, becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from June 2, 2018 through May 2, 2019.
Billionaire Hedge Funds
